Evidence map›Paper›PMID 26097888›Full record

ArticleOncoscience2015

TALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.

Tom Van Nieuwenhuysen, Thomas Naert, Hong Thi Tran, Griet Van Imschoot, Sarah Geurs, Ellen Sanders, David Creytens, Frans Van Roy, Kris Vleminckx

Open access · diamondAbstract read
In one paragraph

Article in Oncoscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Spontaneous neoplasia in the western clawed frogmicroPublication biology · 2020
    Article
  6. Review
  7. Frontiers in physiology · 2019
    Article
  8. Xenbase: Facilitating the Use ofFrontiers in physiology · 2019
    Review
  9. Applications of Genome Editing Technology in Animal Disease Modeling and Gene Therapy.Computational and structural biotechnology journal · 2019
    Review
  10. Article
  11. Frontiers in physiology · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. The genetic basis of colonic adenomatous polyposis syndromes.Hereditary cancer in clinical practice · 2017
    Review
  16. Article
  17. Article
  18. Mechanisms of gene targeting in higher eukaryotes.Cellular and molecular life sciences : CMLS · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tom Van NieuwenhuysenDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Thomas NaertDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Hong Thi TranDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Griet Van ImschootDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Sarah GeursDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Ellen SandersMolecular Cell Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Inflammation Research Center, Flanders Institute for Biotechnology (VIB), Ghent, Belgium.
David CreytensDepartment of Pathology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Frans Van RoyMolecular Cell Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Inflammation Research Center, Flanders Institute for Biotechnology (VIB), Ghent, Belgium.
Kris VleminckxDevelopmental Biology Unit, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium ; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Ghent University · BEGhent University Hospital · BEVIB-UGent Center for Inflammation Research · BEVlaams Instituut voor Biotechnologie · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Truncating mutations in the tumor suppressor gene adenomatous polyposis coli (APC) are the initiating step in the vast majority of sporadic colorectal cancers, and they underlie familial adenomatous polyposis (FAP) syndromes. Modeling of APC- driven tumor formation in the mouse has contributed substantially to our mechanistic understanding of the associated disease, but additional models are needed to explore therapeutic opportunities and overcome current limitations of mouse models. We report on a novel and penetrant genetic cancer model in Xenopus tropicalis, an aquatic tetrapod vertebrate with external development, diploid genome and short life cycle. Tadpoles and froglets derived from embryos injected with TAL effector nucleases targeting the apc gene rapidly developed intestinal hyperplasia and other neoplasms observed in FAP patients, including desmoid tumors and medulloblastomas. Bi-allelic apc mutations causing frame shifts were detected in the tumors, which displayed activation of the Wnt/β-catenin pathway and showed increased cellular proliferation. We further demonstrate that simultaneous double bi-allelic mutation of apc and a non-relevant gene is possible in the neoplasias, opening the door for identification and characterization of effector or modifier genes in tumors expressing truncated apc. Our results demonstrate the power of modeling human cancer in Xenopus tropicalis using mosaic TALEN-mediated bi-allelic gene disruption.

Indexed as

animal modelAPCdesmoid tumorsIntestinal cancerWnt signaling

Identifiers

PMID26097888
PMCPMC4468341
OpenAlexW2188174990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.